Items Tagged ‘#cell therapies’
March 21, 2023
Advancing promising therapies through regulatory programs
Learn about the latest regulatory programs designed to accelerate promising new therapies toward clinical care at the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2023. The event featuring nationally and internationally known speakers will be held April 3–5 at the Westin Kierland Resort and Spa in Scottsdale, Arizona. Peter Marks, M.D., Ph.D., director of […]
Tags: #cell therapies, #Dr. Peter Marks, #Dr. Richard Hayden, #Food and Drug Administration, #Mayo Clinic Center for Regenerative Biotherapeutics, #Mayo Clinic Symposium on Regenerative Medicine & Surgery, #Regenerative Medicine Advance Therapy
August 31, 2022
Center for Regenerative Biotherapeutics announces cell and gene therapy accelerator
Mayo Clinic, Hibiscus BioVentures (Hibiscus) and Innoforce announce the launch of Mayflower BioVentures, a cell and gene therapy accelerator dedicated to identifying and forming companies around technologies that address unmet patient needs. This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies through preclinical […]
Tags: #Business accelerator, #cell therapies, #gene therapie, #Hibiscus BioVentures, #Innoforce, #Mayo Clinic Center for Regenerative Biotherapeutics
February 25, 2022
Unleashing the body’s ability to heal
“We are the patient’s last, best hope,” has been the motto of the Immune, Progenitor and Cell Therapeutics lab, also known as the IMPACT lab, at Mayo Clinic. This lab specializes in clinical and investigative use of cells as living drugs within the body to fight disease and initiate healing when standard therapies don’t work. […]
Tags: #cell therapies, #Department of Laboratory Medicine and Pathology, #Dr. Allan Dietz, #Immune Progenitor and Cell Therapy Lab, #Mayo Clinic Center for Regenerative Medicine
January 20, 2022
Preparing to deliver next-generation therapeutics
Mayo Clinic is among the academic medical centers on the cusp of biomanufacturing next-generation cell and gene therapies that offer hope of new cures for rare and complex diseases. Biomanufacturing this new era of biologic medicines is much different than manufacturing pharmaceuticals from complex molecules. It requires highly specialized lab infrastructure, new processes and new […]
Tags: #CAR T-Therapy, #cell therapies, #Dr. Allen Dietz, #Dr. Michael Gustafson, #Mayo Clinic Center for Regenerative Medicine